Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Arthritis Prevention
Research from University of Valencia provides new data about arthritis prevention
March 2nd, 2007
Researchers detail in "Cucurbitacin R reduces the inflammation and bone damage associated with adjuvant arthritis in lewis rats by suppression of tumor necrosis factor-alpha in T lymphocytes and macrophages," new data in arthritis. According to recent research published in the Journal of Pharmacology and Experimental Therapeutics, "The aim of this study was to investigate the effects of cucurbitacin R on an experimental model of adjuvant-induced arthritis in rats. The treatment of arthritic rats with cucurbitacin R (1 mg/kg p.o. daily) modified the evolution of the clinical symptoms, whereas the histopathology of paws demonstrated a reduction in the signs of arthritis."...
Source: Drug Week (2007-03-02)
|
|
Advertisement |
|
|
|
